{"disease":{"id":"kidney-neoplasm","name":"kidney neoplasm"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05526599","title":"The Association of Marital Status With Kidney Cancer Surgery Morbidity","phase":"","overall_status":"COMPLETED","enrollment_count":106752,"lead_sponsor_name":"Beijing Tsinghua Chang Gung Hospital","has_results":false},{"nct_id":"NCT02402244","title":"Project: Every Child for Younger Patients With Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":75000,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT00898365","title":"Study of Kidney Tumors in Younger Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8000,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT02465060","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6452,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04955808","title":"Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery","phase":"","overall_status":"SUSPENDED","enrollment_count":2400,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05334069","title":"Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT03160274","title":"Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"The University of Texas Health Science Center at San Antonio","has_results":false},{"nct_id":"NCT03301493","title":"Genomic Testing and Resulting Medical Decisions","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Arbeitsgemeinschaft medikamentoese Tumortherapie","has_results":false},{"nct_id":"NCT04669366","title":"Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries","phase":"","overall_status":"COMPLETED","enrollment_count":1205,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05363072","title":"A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.","phase":"","overall_status":"COMPLETED","enrollment_count":1112,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT07004426","title":"Symptomatic and Incidental RCC Detection","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Charles University, Czech Republic","has_results":false},{"nct_id":"NCT04681690","title":"German National Registry for NSS","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Association of Urologic Oncology (AUO)","has_results":false},{"nct_id":"NCT00033137","title":"Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":950,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00678392","title":"Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":723,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT00375674","title":"A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":674,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT00001803","title":"Von Hippel-Lindau Disease Genetic Epidemiology Study","phase":"","overall_status":"TERMINATED","enrollment_count":546,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00920816","title":"Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":492,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06903312","title":"Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":409,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03977571","title":"Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Niels Fristrup","has_results":false},{"nct_id":"NCT00303719","title":"Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":342,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":true},{"nct_id":"NCT03866382","title":"Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":314,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05729763","title":"Three-dimensional Virtual Imaging to Improve the Accuracy of Standard CT-based Nephrometric Scores: a Prospective Multicentric Observational Study","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"San Luigi Gonzaga Hospital","has_results":false},{"nct_id":"NCT05184790","title":"LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of Sydney","has_results":false},{"nct_id":"NCT04213157","title":"Laparoscopic Partial Nephrectomy for cT1 Tumors","phase":"","overall_status":"COMPLETED","enrollment_count":292,"lead_sponsor_name":"Samsun Liv Hospital","has_results":false},{"nct_id":"NCT01117779","title":"Tracking Renal Tumors After Cryoablation Evaluation","phase":"","overall_status":"TERMINATED","enrollment_count":246,"lead_sponsor_name":"Boston Scientific Corporation","has_results":true},{"nct_id":"NCT06536439","title":"Planning Operative Strategy Using a Digital Renal Artery Clamping Tool","phase":"NA","overall_status":"RECRUITING","enrollment_count":235,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT06349668","title":"Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Hans Bahlmann","has_results":false},{"nct_id":"NCT05184504","title":"Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American","phase":"","overall_status":"COMPLETED","enrollment_count":211,"lead_sponsor_name":"Latin American Cooperative Oncology Group","has_results":false},{"nct_id":"NCT05887245","title":"Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Centre of Postgraduate Medical Education","has_results":false},{"nct_id":"NCT05068180","title":"Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT05135832","title":"Patient Reported Outcomes by Patients With Metastatic Renal Cell Carcinoma","phase":"NA","overall_status":"UNKNOWN","enrollment_count":174,"lead_sponsor_name":"Herlev and Gentofte Hospital","has_results":false},{"nct_id":"NCT04028479","title":"The Registry of Oncology Outcomes Associated With Testing and Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Taproot Health","has_results":false},{"nct_id":"NCT02721732","title":"Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":157,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT02496208","title":"Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":152,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05218811","title":"Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Urological Research Network, LLC","has_results":false},{"nct_id":"NCT05790122","title":"Safety and Efficacy of Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1 Stage Renal Carcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":146,"lead_sponsor_name":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT04071223","title":"Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":134,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07234409","title":"Clinical Trial Addressing the Best Surgical Approach for Partial Nephrectomy With Single Port Robotic System in the Management of Localized Renal Cell Carcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":124,"lead_sponsor_name":"Niguarda Hospital","has_results":false},{"nct_id":"NCT05119335","title":"A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":120,"lead_sponsor_name":"NiKang Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05842044","title":"NSAID Use After Robotic Partial Nephrectomy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT02867592","title":"Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":109,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT03996850","title":"SPECT/CT for the Characterization of Renal Masses","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":102,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT04513522","title":"A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT03444766","title":"Study of Nivolumab for Advanced Cancers in India","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT06467097","title":"Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT05286801","title":"Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":86,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06715878","title":"Zero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 Stage","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT02077933","title":"Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04933604","title":"LPN in Patients With High-complex Renal Tumors","phase":"","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Samsun Liv Hospital","has_results":false},{"nct_id":"NCT01688999","title":"Cabozantinib for Advanced Urothelial Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}